Frontiers in Psychiatry | Psychopharmacology

Editorial

Published on 06 May 2024

Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions

in Psychopharmacology

Jennifer L. McLaren
Julie M. Zito
Jörg M. Fegert
Erin R. Barnett

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1418600

5,259 views
1 citation

Case Report

Published on 29 Apr 2024

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

in Psychopharmacology

Florine M. Wiss
Samuel S. Allemann
Henriette E. Meyer zu Schwabedissen
Céline K. Stäuble
Thorsten Mikoteit
Markus L. Lampert

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1397876

4,478 views
2 citations

Case Report

Published on 26 Apr 2024

Case report: Escitalopram-associated lower limb edema

in Psychopharmacology

Mohamed Hassan Ahmed
Mena Al-Kubaisi
Safa Abdulmajeed Al-Rawi
Omar Hosam Salama
Hebah Mahmoud Abutayyem

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1394813

8,429 views
1 citation

Perspective

Published on 18 Apr 2024

Psychiatric and legal considerations for ketamine treatment within prison settings

in Psychopharmacology

Michael Bayrhammer-Savel
Martin Ortner
Marie-Claire Van Hout
Arkadiusz Komorowski

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1316108

3,240 views
6 citations

Original Research

Published on 18 Apr 2024

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

in Psychopharmacology

Julia Ruixi Wang
Samuel J. Mendez Araque
Gina Micciche
Andrew McMillan
Emily Coughlin
Rosalie Mattiola
Diana English
Kristopher Kaliebe

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1301960

5,933 views
5 citations

Original Research

Published on 10 Apr 2024

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees

in Psychopharmacology

Matthew X. Lowe
Hannes Kettner
Del R. P. Jolly
Robin L. Carhart-Harris
Heather Jackson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1279887

9,344 views
5 citations

Original Research

Published on 09 Apr 2024

Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study

in Psychopharmacology

Katharina Wien
Julia Thern
Anika Neubert
Britta-Lena Matthiessen
Stefan Borgwardt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1304844

3,635 views
8 citations

Original Research

Published on 04 Apr 2024

Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice

in Psychopharmacology

Elissa K. Fultz
Andrea Y. T. Nei
Joyce C. Chi
Jacqueline N. Lichter
Karen K. Szumlinski

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1297275

1,958 views
1 citation

Original Research

Published on 03 Apr 2024

Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study

in Psychopharmacology

Petra Truedson
Michael Ott
Lisa Wahlström
Robert Lundqvist
Martin Maripuu
Krister Lindmark
Ingrid Lieber
Ursula Werneke

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1358461

3,792 views
2 citations

General Commentary

Published on 25 Mar 2024

Commentary: Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

in Psychopharmacology

Tycho J. Dekkers

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1383492

5,621 views
3 citations

Case Report

Published on 19 Mar 2024

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics

in Psychopharmacology

Liam Korošec Hudnik
Tanja Blagus
Sara Redenšek Trampuž
Vita Dolžan
Jurij Bon
Milica Pjevac

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1363051

5,215 views
5 citations

Systematic Review

Published on 08 Mar 2024

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

in Psychopharmacology

Alexandros Matsingos
Marcel Wilhelm
Laila Noor
Cüneyt Yildiz
Winfried Rief
Stefan G. Hofmann
Irina Falkenberg
Tilo Kircher

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1346697

7,944 views
17 citations

Editorial

Published on 28 Feb 2024

Editorial: Reviews in psychiatry 2022: psychopharmacology

in Psychopharmacology

Maris Taube

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1382027

2,259 views

Original Research

Published on 22 Feb 2024

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey

in Psychopharmacology

Nicolas G. Glynos
Jacob S. Aday
Daniel Kruger
Kevin F. Boehnke
Stephanie Lake
Philippe Lucas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1349565

7,903 views
10 citations

Case Report

Published on 20 Feb 2024

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy

in Psychopharmacology

Christopher P. Harris
Becky Jones
Kathryn Walker
Meredith S. Berry

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1322679

8,537 views
1 citation

Brief Research Report

Published on 19 Feb 2024

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression

in Psychopharmacology

Aleksander Kwaśny
Wiesław Jerzy Cubała
Adam Włodarczyk

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1334293

5,140 views
5 citations

Case Report

Published on 07 Feb 2024

Hypothyroidism and sinus dysfunction associated with lithium-paliperidone combination therapy for bipolar disorder with psychotic symptoms: a case report

in Psychopharmacology

Wenjian Wei
Yonglan Yang
Haifeng Wang
Yunbin Yang
Jizhou Liu
Jinfeng Li

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1336100

3,560 views
1 citation

Systematic Review

Published on 05 Feb 2024

Keeping the promise: a critique of the current state of microdosing research

in Psychopharmacology

Rotem Petranker
Thomas Anderson
Emily C. Fewster
Youval Aberman
Marik Hazan
Michael Gaffrey
Paul Seli

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1217102

9,475 views
10 citations

Hypothesis and Theory

Published on 01 Feb 2024

Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach

in Psychopharmacology

Phil Wolfson
Gita Vaid

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1209419

17,180 views
14 citations

Editorial

Published on 24 Jan 2024

Editorial: Case reports in psychopharmacology

in Psychopharmacology

Matej Stuhec
Patricia Di Ciano

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1364711

1,867 views
1 citation

Original Research

Published on 23 Jan 2024

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

in Psychopharmacology

Johannes Hauser
Jan Sarlon
Timur Liwinski
Annette B. Brühl
Undine E. Lang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1327598

6,738 views
10 citations

Original Research

Published on 17 Jan 2024

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

in Psychopharmacology

Isabel Hach
Thomas Bertsch
Patrick Nonell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1240681

3,227 views
2 citations

Clinical Trial

Published on 16 Jan 2024

Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial

in Psychopharmacology

Seyed Shahab Banihashem
Seyedeh Mahsa Mofatioshieh
Reyhaneh Rastegar
Amir Sadeghi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1297231

10,808 views
6 citations

Original Research

Published on 11 Jan 2024

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

in Psychopharmacology

Ellen James
David Erritzoe
Tiffanie Benway
Zelah Joel
Christopher Timmermann
Meghan Good
Claudio Agnorelli
Brandon M. Weiss
Tommaso Barba
Graham Campbell

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1305796

7,752 views
14 citations

609 articles

articles

Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Case report: Escitalopram-associated lower limb edema

Psychiatric and legal considerations for ketamine treatment within prison settings

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees

Reduced prevalence of drug-related problems in psychiatric inpatients after implementation of a pharmacist-supported computerized physician order entry system - a retrospective cohort study

Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice

Serious adverse drug events associated with psychotropic treatment of bipolar or schizoaffective disorder: a 17-year follow-up on the LiSIE retrospective cohort study

Commentary: Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis

Editorial: Reviews in psychiatry 2022: psychopharmacology

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey

Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy

Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression

Hypothyroidism and sinus dysfunction associated with lithium-paliperidone combination therapy for bipolar disorder with psychotic symptoms: a case report

Keeping the promise: a critique of the current state of microdosing research

Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach

Editorial: Case reports in psychopharmacology

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents

Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial